Home » Newsletters » BioWorld Science

BioWorld Science

April 16, 1999

View Archived Issues

Final analysis presented for phase II Altropane diagnosis trial

Celsion signs option agreement for cancer therapy technology

Data on adefovir dipivoxil against HBV presented at EASL conference

News from AACR: chemopreventive properties of NSAIDs, including COX-2 inhibitors

U.K approval of Atrix's periodontal drug delayed

Inhibitex signs research agreement with BioResearch Ireland

U.K. team develops novel male contraceptive methodology

Pivotal studies of anti-HIV drug candidate under way on three continents

Preclinical and clinical results support efficacy of Trovert in treatment of acromegaly

New series of osteogenesis-promoting agents developed at Taisho

Differentiation-inducing vitamin D derivatives described by Teikoku Hormone

Compounds and methods for treating or diagnosing leishmaniasis disclosed by Corixa

Takeda presents new tachykinin antagonists

Pharmacokinetics and MTD of BBR-2778 determined in cancer patients

Estrogen/antiandrogenic progesterone combination for hirsutism: efficacy of long-term Rx

In vitro and in vivo profile of AG-7352 described in further detail at AACR meeting

Korean researchers report preclinical toxicity and pharmacokinetics of CKD-602 continuous infusion

Presence of GHRH receptor is essential for response to treatment with GHRPs

U.K. launch announced for anticonvulsant prodrug

EntreMed paves the way for clinical evaluation of recombinant human Endostatin

Vion presents parent and prodrug ribonucleotide reductase inhibitors at AACR

Jenapharm's scavestrogen is more potent than estrogen in preventing atherosclerosis

New taxane analogue shows potential as an orally active alternative to paclitaxel

Canadian approval obtained, launch imminent for Celebrex

Low-dose IL-2 provides benefits in treatment-refractory HCV patients

Two gene therapy approaches shown effective in treating hepatocellular carcinoma in rats

Merger of Nippon Glaxo and Nippon Wellcome

Good tolerance and in vivo proteasome inhibition demonstrated for multiple doses of PS-341

Phytopharm opens new facility for manufacture of antiobesity drug

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...